Study finds metformin reduces COVID-19 viral load, viral rebound
A simulator developed by Prof. David Odde and his team was used in a phase 3 randomized clinical trial published in Clinical Infectious Diseases.
Study shows metformin lowers the risk of getting long COVID
A simulator developed by Prof. David Odde and his team was used in a large, placebo-controlled randomized clinical trial published in The Lancet Infectious Diseases.
Shapeshifters: Can buildings behave like organisms?
The project — which includes Prof. David Odde — reimagines the convergence of architecture and biology to understand how organisms create internal structures.
Undergraduate student Ibrahim Irfanullah receives Fulbright award
Irfanullah plans to work on a project in Brazil aimed at applying techniques in machine learning and artificial intelligence to develop affordable and accessible technologies for hepatocellular carcinoma.
How University of Minnesota scientists use disease simulators to evaluate potential treatments
Dave shares how disease simulators have the potential to power up the potency of clinical trials, making their chances of success far better than they are today.
Computer simulator helps steer COVID-19 clinical trial toward promising treatment
The biophysics-based model from Dave and team simulated the disease on a molecular and cellular level so the trial team could screen potential treatments computationally long before they were given to participants.
Research finds cancer cells can migrate toward certain ‘sweet spot’ environments
Dave and team have found that cancer cells can gravitate toward certain mechanical “sweet spot” environments, providing new insights into how cancer invades the body.
New $9.6M grant to accelerate new cancer immunotherapeutics
A biophysics-based tumor simulator will be developed by BME faculty, thanks to a P01 grant from the National Cancer Institute.
PhD student Ghaidan Shamsan successfully defends dissertation
Ghaidan Shamsan has successfully defended his dissertation, "Mechanical Regulation of Glioma Cell Migration".
Developing a simulator to predict COVID-19 trial outcomes
Dave is creating a biophysical computer model that simulates COVID-19 on a molecular and cellular level, and tests therapies and vaccines computationally.